All filters
Abstracts
LACTIN-V Treatment for Recurrent Bacterial Vaginosis
L. Lagenaur
Â
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Abstracts
Impact of contraceptive use on vaginal microbiome in adolescent girls
A. Aldous
Â
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Abstracts
Baseline gut microbiome dysbiosis predicts gut microbiome response to ART/co-trimoxazole treatment in HIV-positive individuals in rural and urban Zimbabwe
A. Lazzaro
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Abstracts
Alteration of the gut fecal microbiome in HIV infected children on anti-retroviral therapy in Yaounde, Cameroon
C. Martin
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Abstracts
A FAST FORWARD INVESTIGATIVE FORECASTING: Challenges, Unmet Needs and Gaps of the New HIV Prevention Technologies (NPT) in a Malawian Context
D. Mahwayo
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Abstracts
Comparative analysis of vaginal microbiota sampling using the menstrual cups and high vaginal swabs in HIV-1 infected pregnant women
C. Short
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Online Education
Highlights of the Symposium on Managing Today’s Complex HIV Patient
24 Oct 2019 - 24 Oct 2020
Slidesets
Clinical Update: Highly Treatment- Experienced Patients - Michael Kozal, MD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Clinical Case: Potential Challenges of Drug Interactions of Long-Acting Agents - Catia Marzolini, PharmD, PhD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
HIV Prevention: The Second Wave of Choices - Richard Elion, MD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
HIV Vaccines - Where Are We? - Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Therapeutic approaches for a sustainable remission and cure - Steven Deeks, MD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Starting Long-Acting Drugs in the COVID-19 Era - Anton Pozniak, MD, FRCP
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Introducing New Therapies in Middle-Income Countries - Pedro Cahn, MD, PhD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Strategies for Management of Drug-Drug Interactions With Long-Acting Therapies - David Back, PhD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
How and When to Monitor Patients On Long-Acting Antivirals? - Monica Gandhi, MD, MPH
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Clinical Case: Reduced Drug Therapy - Mary Montgomery, MD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Implications for Women's Health - Sharon Walmsley, MD, FRCPC, CM
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Implications for Sanctuary Sites and Drug Interactions - Marta Boffito, MD, PhD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Implications of Drug Resistance for the HIV Pandemic - Robert Shafer,MD
Presented at:
Global HIV Clinical Forum 2020
Slidesets
Long Acting Injectable Antiretroviral Therapy - Martin Markowitz, MD
Presented at:
Global HIV Clinical Forum 2020
Meeting Report
HIV&Aging 2020-Polypharmacy in 94% of Older HIV Group, Inappropriate Meds Frequent
Presented at:
International Workshop on HIV & Aging 2020
Meeting Report
HIV&Aging 2020-Latent Class Analysis--Unique Predictor of Hospitalization, Death in Older HIV+
Presented at:
International Workshop on HIV & Aging 2020
Meeting Report
HIV&Aging 2020 - Sex Hormone-Binding Globulin Tied to Frailty, Low BMD in Women, Not Men
Presented at:
International Workshop on HIV & Aging 2020